BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 15, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 13, 2001
View Archived Issues
First nonpeptide somatotropin sst3 antagonists reported
Read More
Genzyme acquires Novazyme Pharmaceuticals
Read More
Enrollment completed in second phase III trial of ranolazine for chronic angina
Read More
Phase I results reported for Merck KGaA's anti-EGF receptor MAb
Read More
Patient enrollment for phase I study of RIGScan CR set to begin
Read More
Colon cancer proteomics discovery partnership signed by Genomics Collaborative and ActivX
Read More
EMEA awards orphan product status to Surfaxin for MAS
Read More
Desloratadine approved in the E.U. for symptoms of chronic idiopathic urticaria
Read More
Strategy for systemic administration of Reolysin explored
Read More
Merck & Co. reports novel farnesyltransferase inhibitor with excellent cell potency
Read More
Compounds useful as cell adhesion inhibitors patented by Aventis and Genentech
Read More
Taisho identifies PGD2-like agonists potentially useful for cardiovascular disorders
Read More
PG derivatives for prevention and treatment of vascular hypertrophy described by Taisho
Read More
NK1 antagonists useful for treating asthma and allergic rhinitis reported by UCB
Read More
COR Therapeutics reports new selective factor Xa inhibitors
Read More
Quadruple therapy including both nelfinavir and efavirenz improves response in HIV patients
Read More
Copaxone approved by 15 European countries for the treatment of MS
Read More
Transtec receives marketing approval in Germany for the treatment of nonacute pain
Read More
FDA advisory committee recommends approval of Tracleer for PAH
Read More